SCHEMBL30464945

SCHEMBL30464945

COCCOc1cc(C(=O)O)ccn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4C Q9H3R0 9/20 0.50
▸ KDM2A Q9Y2K7 4/20 0.50
▸ KDM3A Q9Y4C1 4/20 0.50
▸ KDM4E B2RXH2 4/20 0.50
▸ KDM6B O15054 3/20 0.50
▸ KDM5C P41229 3/20 0.50
▸ KDM5A P29375 5/20 0.47
▸ KDM5B Q9UGL1 5/20 0.47
▸ KDM4A O75164 2/20 0.47
▸ KDM4D Q6B0I6 2/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ TET3 O43151 1/20 0.47
▸ BBOX1 O75936 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ ASPH Q12797 1/20 0.47
▸ TET2 Q6N021 1/20 0.47
▸ ALKBH5 Q6P6C2 1/20 0.47
▸ KDM7A Q6ZMT4 1/20 0.47
▸ KDM8 Q8N371 1/20 0.47
▸ TET1 Q8NFU7 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2585341 1.00 KDM4C (0.50) KDM4CKDM2AKDM3AKDM4EKDM6B
SCHEMBL13490849 0.92 KDM4C (0.49) KDM4CKDM2AKDM3AKDM4EKDM6B
SCHEMBL2590131 0.86 KDM4E (0.53) KDM4CKDM2AKDM3AKDM4EKDM6B
SCHEMBL17276016 0.86 IKBKB (0.47) KDM5CKDM5BACACBLOXL2
SCHEMBL25049489 0.85 KDM4C (0.57) KDM4CKDM2AKDM3AKDM4EKDM6B
SCHEMBL12800159 0.84 KDM4C (0.45) KDM4CKDM2AKDM3AKDM4EKDM6B
SCHEMBL31729821 0.84 TP53 (0.55) KDM4CKDM5AKDM5B
SCHEMBL17412498 0.84 PLA2G2A (0.55) KDM4CKDM5AKDM5BALDH1A1
SCHEMBL2546283 0.83 KDM4C (0.50) KDM4CKDM2AKDM3AKDM4EKDM6B
SCHEMBL1992514 0.81 MAPT (0.57) KDM4CKDM2AKDM3AKDM4EKDM6B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116529246-A N- [ (1, 3-benzoxazol-2-yl) -heterocycle ] amide derivatives for the treatment and prevention of hepatitis b virus infection 豪夫迈·罗氏有限公司 2023-08-01 — — CN disclosed
Send feedback